Clinical Trial Update: Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sintilimab to pembrolizumab for advanced non-small cell lung cancer is ongoing with unpublished status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Sintilimab (sintilimab)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Nsclc | Phase 2 | Status: UNKNOWN